7TM Pharma successfully conducts clinical phase I trial with its second generation CB1 receptor antagonist

Press Release Thursday, February 04, 2010

7TM Pharma closes a financing round and sells certain early stage discovery assets and technology to OSI Pharmaceuticals

Press Release Thursday, January 15, 2009